WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it will preview its newest product - NC-stat® | DPNCheck™ - at the Annual Meeting of the American Association of Clinical Endocrinologists (AACE), taking place April 13-17 in San Diego, CA. NC-stat® | DPNCheck™ is a fast, accurate, and quantitative test for the evaluation of systemic neuropathies such as diabetic peripheral neuropathy (DPN).
